Comparative cardiovascular risk in users versus non-users of xanthine oxidase inhibitors and febuxostat versus allopurinol users
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative cardiovascular risk in users versus non-users of xanthine oxidase inhibitors and febuxostat versus allopurinol users
Authors
Keywords
-
Journal
RHEUMATOLOGY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-10-31
DOI
10.1093/rheumatology/kez576
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of allopurinol and febuxostat on cardiovascular mortality in elderly heart failure patients
- (2019) Arrigo Francesco Giuseppe Cicero et al. Internal and Emergency Medicine
- Relative Performance of Propensity Score Matching Strategies for Subgroup Analyses
- (2018) Shirley V Wang et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation
- (2018) Richard J. Johnson et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials
- (2018) Markus Bredemeier et al. BMC Cardiovascular Disorders
- Assessment of Cardiovascular Risk in Older Patients with Gout Initiating Febuxostat versus Allopurinol: A Population-Based Cohort Study
- (2018) MaryAnn Zhang et al. CIRCULATION
- Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer
- (2018) Thomas N.Y. Kwong et al. GASTROENTEROLOGY
- Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
- (2018) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Implications of the cardiovascular safety of febuxostat and allopurinol in patients with gout and cardiovascular morbidities (CARES) trial and associated FDA public safety alert
- (2018) Hyon Choi et al. Arthritis & Rheumatology
- A review of the performance of different methods for propensity score matched subgroup analyses and a summary of their application in peer-reviewed research studies
- (2017) Shirley V. Wang et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Allopurinol as a therapeutic option in cardiovascular disease
- (2017) Osita N Okafor et al. PHARMACOLOGY & THERAPEUTICS
- Cardiovascular effects of urate-lowering therapies in patients with chronic gout: a systematic review and meta-analysis
- (2017) Tony Zhang et al. RHEUMATOLOGY
- Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study
- (2017) Kenneth K C Man et al. BMJ-British Medical Journal
- Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study
- (2017) Kenneth K C Man et al. BMJ-British Medical Journal
- Effect of Allopurinol on Cardiovascular Outcomes in Hyperuricemic Patients: A Cohort Study
- (2016) Kasper Søltoft Larsen et al. AMERICAN JOURNAL OF MEDICINE
- 2016 updated EULAR evidence-based recommendations for the management of gout
- (2016) P Richette et al. ANNALS OF THE RHEUMATIC DISEASES
- Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system
- (2016) K K C Man et al. Translational Psychiatry
- Reactive Oxygen Species, Endoplasmic Reticulum Stress and Mitochondrial Dysfunction: The Link with Cardiac Arrhythmogenesis
- (2016) Gary Tse et al. Frontiers in Physiology
- Effects of Xanthine Oxidase Inhibitors on Cardiovascular Disease in Patients with Gout: A Cohort Study
- (2015) Seoyoung C. Kim et al. AMERICAN JOURNAL OF MEDICINE
- Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims
- (2015) Daniel H Solomon et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study
- (2015) M. M. Givertz et al. CIRCULATION
- Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study
- (2015) Esther W. Chan et al. GASTROENTEROLOGY
- Comparison of febuxostat and allopurinol for hyperuricemia in cardiac surgery patients with chronic kidney disease (NU-FLASH trial for CKD)
- (2015) Akira Sezai et al. Journal of Cardiology
- Improving cardiovascular and renal outcomes in gout: what should we target?
- (2014) Pascal Richette et al. Nature Reviews Rheumatology
- Allopurinol Therapy in Gout Patients Does Not Associate with Beneficial Cardiovascular Outcomes: A Population-Based Matched-Cohort Study
- (2014) Victor C. Kok et al. PLoS One
- Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia
- (2014) T. M. MacDonald et al. BMJ Open
- Anti-Inflammatory Treatment With Colchicine in Stable Chronic Heart Failure
- (2014) Spyridon Deftereos et al. JACC-Heart Failure
- CArdiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular ComoRbiditiES
- (2012) William B. White et al. AMERICAN HEART JOURNAL
- Serum uric acid is an independent risk factor for cardiovascular disease and mortality in hypertensive patients
- (2012) Tatsuo Kawai et al. HYPERTENSION RESEARCH
- Changes in Uric Acid Levels and Allopurinol Use in Chronic Heart Failure: Association With Improved Survival
- (2012) Israel Gotsman et al. JOURNAL OF CARDIAC FAILURE
- The Worldwide Environment of Cardiovascular Disease: Prevalence, Diagnosis, Therapy, and Policy Issues
- (2012) Lawrence J. Laslett et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Allopurinol as a Cardiovascular Drug
- (2011) Anita Kelkar et al. Cardiology in Review
- Xanthine Oxidase Inhibition For The Treatment Of Cardiovascular Disease: A Systematic Review and Meta-Analysis
- (2011) Peter Higgins et al. Cardiovascular Therapeutics
- Effect of the Treatment with Allopurinol on the Endothelial Function in Patients with Hyperuricemia
- (2011) Gabriela Meléndez-Ramírez et al. ENDOCRINE RESEARCH
- Febuxostat inhibition of endothelial-bound XO: Implications for targeting vascular ROS production
- (2011) Umair Z. Malik et al. FREE RADICAL BIOLOGY AND MEDICINE
- Impact of allopurinol use on urate concentration and cardiovascular outcome
- (2010) Li Wei et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Febuxostat: a new treatment for hyperuricaemia in gout
- (2009) N. L. Edwards RHEUMATOLOGY
- Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28-week, phase III, randomized, double-blind, parallel-group trial
- (2008) H. RALPH Schumacher et al. ARTHRITIS AND RHEUMATISM
- Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: A prospective 21-year follow-up study
- (2008) Alexander M. Strasak et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More